Michaël Prakesch

Statistics

Publications

Citations

860

H-Index

Active since

2001

Affiliations

Ontario Institute for Cancer Research(Current)

University of Toronto

Steacie Institute for Molecular Sciences

Centre National de la Recherche Scientifique

Lunenfeld-Tanenbaum Research Institute

Michaël Prakesch is an author at Ontario Institute for Cancer Research specializing in natural sciences, organic chemistry, and biomolecular engineering.

ORCID

Top concepts

Natural SciencesChemistryPharmacologyOrganic ChemistryBiomolecular EngineeringEngineeringMedicineBiochemistryCell BiologyTumor Biology

Publications per year

2001–2023

Publications

Structure and mechanism of action of the hydroxy–aryl–aldehyde class of IRE1 endoribonuclease inhibitors

Mário Sanches, Nicole M. Duffy, Manisha Talukdar et al. · Nature Communications · 2014 · 130 citations · Full text

Molecular Pharmacology, Aldehyde Dehydrogenase, Biochemistry +9

Functional characterization of a PROTAC directed against BRAF mutant V600E

Ganna Posternak, Xiaojing Tang, Pierre Maisonneuve et al. · Nature Chemical Biology · 2020 · 127 citations · Full text

Natural Sciences, Protein Biosynthesis, Braf Mutant V600e +4

Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells

Natalie Grinshtein, Alessandro Datti, Mayumi Fujitani et al. · Cancer Research · 2011 · 98 citations

Glioma, Tumor Biology, Neuro-oncology +17

PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma

Yael Babichev, Leah Kabaroff, Alessandro Datti et al. · Journal of Translational Medicine · 2016 · 52 citations · Full text

The Propargylic Route as a Short and Versatile Entry to Optically Active Monofluorinated Compounds

Michaël Prakesch, Danielle Grée, René Grée · Accounts of Chemical Research · 2002 · 41 citations

Asymmetric Catalysis, Propargylic Route, Optical Materials +15

Rows per page

1–5 of 23